Maravai LifeSciences rises on surprise Q4 profit
** Shares of biotech co Maravai LifeSciences Holdings
MRVI.O rise 29.8% to $6.63 premarket
** Co late on Thursday reported quarterly adj profit of 1
cent per share vs analysts' estimates for loss of 1 cent per
share - LSEG data
** Co posted Q4 revenue of $74.14 mln, beating estimates of
$64.38 mln
** Sees 2024 revenue in the range of $265 mln to $285 mln
vs analysts' estimates of $271.88 mln
** Stock has fallen 63% in the last 12 months
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million